Literature DB >> 29665516

'Cool' and 'Hot' executive functions in suicide attempters with major depressive disorder.

Ming-Chou Ho1, Yi-Chieh Hsu2, Mong-Liang Lu3, Michael Gossop4, Vincent Chin-Hung Chen5.   

Abstract

RATIONALE: The World Health Organization reports that, by 2030, depression is expected to be the largest contributor to disease burden. Only small proportion of patients with major depressive disorder (MDD) achieves remission and the majority of them do not achieve long-term functional recovery. One of the neuropsychological domains that have been shown to be particularly impaired in depression, is that of executive function (EF).
OBJECTIVES: We examined whether the patients with MDD with and without suicide attempts had deteriorated 'cool' EF and 'hot' EF.
METHODS: The study population comprised 34 MDD attempters, 36 MDD non-attempters, and 55 healthy controls. We adopted the symmetry span task (SSPAN) to measure the updating and the affective shifting task (AST) to measure the inhibition and set-shifting in general and in response to emotional material. The Iowa gambling task (IGT) was used to examine the affective decision-making ability.
RESULTS: After controlling for PHQ-9, Anxiety (HADS), suicidal ideation, education year and gender, we reported that (1) the MDD non-attempters had worse updating than the healthy controls and the MDD attempters; (2) the MDD attempters had worse general inhibition (GI) than the healthy controls and the MDD non-attempters; (3) the MDD non-attempters had worse general set-shifting (GS) than the healthy controls and the MDD attempters; (4) there was no between-group difference in the 'hot' EFs; and (5) MDD attempters with longer durations (over 5 years) since last attempt had worse general inhibition.
CONCLUSIONS: The disrupted 'cool' EFs patients with MDD are consistent with previous review and meta-analytic studies. On the other hand, the two groups with MDD performed similarly to the healthy controls in the 'hot' EF.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Decision-making; Inhibition; MDD; Set-shifting; Suicide; Updating

Mesh:

Year:  2018        PMID: 29665516     DOI: 10.1016/j.jad.2018.04.057

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  Suicidal risk and executive functions in major depressive disorder: a study protocol.

Authors:  Miquel Roca; Antonio Riera-López Del Amo; Pau Riera-Serra; Mª Angeles Pérez-Ara; Adoración Castro; J Roman Juan; Mauro García-Toro; Patricia García-Pazo; Margalida Gili
Journal:  BMC Psychiatry       Date:  2019-08-16       Impact factor: 3.630

2.  A comparative study of amplitude of low-frequence fluctuation of resting-state fMRI between the younger and older treatment-resistant depression in adults.

Authors:  Jifei Sun; Chunlei Guo; Yue Ma; Zhongming Du; Zhi Wang; Yi Luo; Limei Chen; Deqiang Gao; Xiaojiao Li; Ke Xu; Yang Hong; Xue Yu; Xue Xiao; Jiliang Fang; Yong Liu
Journal:  Front Neurosci       Date:  2022-08-25       Impact factor: 5.152

3.  Neurocognition and the Suicidal Process.

Authors:  S B Rutter; N Cipriani; E C Smith; E Ramjas; D H Vaccaro; M Martin Lopez; W R Calabrese; D Torres; P Campos-Abraham; M Llaguno; E Soto; M Ghavami; M M Perez-Rodriguez
Journal:  Curr Top Behav Neurosci       Date:  2020

4.  Association between olfactory function and inhibition of emotional competing distractors in major depressive disorder.

Authors:  Fang Wang; Jin Jin; Jun Wang; Ruoqiao He; Kaiyun Li; Xiaonan Hu; Yongchao Li; Yuncheng Zhu
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

5.  Understanding the Complex of Suicide in Depression: from Research to Clinics.

Authors:  Laura Orsolini; Roberto Latini; Maurizio Pompili; Gianluca Serafini; Umberto Volpe; Federica Vellante; Michele Fornaro; Alessandro Valchera; Carmine Tomasetti; Silvia Fraticelli; Marco Alessandrini; Raffaella La Rovere; Sabatino Trotta; Giovanni Martinotti; Massimo Di Giannantonio; Domenico De Berardis
Journal:  Psychiatry Investig       Date:  2020-03-23       Impact factor: 2.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.